|
Lipocine Inc. (LPCN) Évaluation DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Lipocine Inc. (LPCN) Bundle
Que vous soyez un investisseur ou un analyste, cette calculatrice DCF Lipocine Inc. (LPCN) est votre outil essentiel pour une évaluation précise. Équipé de données réelles de la lipocine, vous pouvez ajuster les prévisions et observer immédiatement les effets.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .2 | .0 | 16.1 | .5 | -2.9 | -.7 | -.2 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | -100 | 0 | -96.9 | -670.16 | -74.23 | -74.23 | -74.23 | -74.23 | -74.23 |
| EBITDA | -12.6 | -18.0 | -.4 | -10.7 | -16.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -7666.19 | 100 | -2.67 | -2144.28 | 572.56 | -0.53346 | -0.53346 | -0.53346 | -0.53346 | -0.53346 |
| Depreciation | .0 | .0 | .0 | .0 | .0 | -.2 | .0 | .0 | .0 | .0 |
| Depreciation, % | 9.36 | 100 | 0.00235428 | 1.89 | -1.01 | 22.05 | 22.05 | 22.05 | 22.05 | 22.05 |
| EBIT | -12.7 | -18.0 | -.4 | -10.7 | -16.4 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -7675.55 | 100 | -2.67 | -2146.17 | 573.57 | -0.53393 | -0.53393 | -0.53393 | -0.53393 | -0.53393 |
| Total Cash | 14.1 | 19.7 | 44.6 | 32.5 | 22.0 | -.4 | -.1 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .2 | .7 | .1 | -.3 | -.1 | .0 | .0 | .0 |
| Account Receivables, % | 10.01 | 100 | 1.53 | 131.97 | -1.83 | 41.94 | 41.94 | 41.94 | 41.94 | 41.94 |
| Inventories | 5.0 | 5.0 | .0 | .0 | .0 | -.3 | -.1 | .0 | .0 | .0 |
| Inventories, % | 3030.49 | 100 | 0 | 0.0002 | 0 | 40 | 40 | 40 | 40 | 40 |
| Accounts Payable | 1.2 | 1.6 | 1.3 | .6 | 1.4 | -.4 | -.1 | .0 | .0 | .0 |
| Accounts Payable, % | 716.55 | 100 | 7.99 | 120.08 | -48.97 | 51.8 | 51.8 | 51.8 | 51.8 | 51.8 |
| Capital Expenditure | .0 | .0 | .0 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 0 | 100 | -0.04702978 | -26.77 | 0.46187 | -5.36 | -5.36 | -5.36 | -5.36 | -5.36 |
| Tax Rate, % | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 | -0.00461736 |
| EBITAT | -12.7 | -18.0 | -.4 | -10.7 | -16.4 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -16.5 | -17.6 | 4.0 | -12.0 | -14.9 | -1.2 | -.2 | -.1 | .0 | .0 |
| WACC, % | 9.82 | 9.82 | 9.82 | 9.82 | 9.82 | 9.82 | 9.82 | 9.82 | 9.82 | 9.82 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | -5 | |||||||||
| Equity Value | 3 | |||||||||
| Diluted Shares Outstanding, MM | 5 | |||||||||
| Equity Value Per Share | 0.64 |
What You Will Get
- Real LPCN Financial Data: Pre-filled with Lipocine Inc.’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Lipocine Inc.’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Financial Inputs: Adjust essential parameters such as revenue projections, operating margins, and research & development expenses.
- Instant DCF Valuation: Quickly computes intrinsic value, net present value (NPV), and other financial metrics.
- High-Precision Results: Leverages Lipocine Inc.'s (LPCN) actual financial data for accurate valuation outputs.
- Effortless Scenario Testing: Easily explore various assumptions and analyze their impact on outcomes.
- Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.
How It Works
- 1. Access the Template: Download and open the Excel file containing Lipocine Inc.'s (LPCN) preloaded data.
- 2. Modify Assumptions: Adjust key parameters such as growth rates, WACC, and capital expenditures.
- 3. Analyze Results Immediately: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Different Scenarios: Evaluate various forecasts to assess different valuation results.
- 5. Present with Assurance: Share professional valuation insights to bolster your decision-making.
Why Choose This Calculator for Lipocine Inc. (LPCN)?
- Designed for Experts: A specialized tool utilized by analysts, CFOs, and investment consultants.
- Accurate Financial Data: Lipocine Inc.'s historical and projected financials are preloaded for precision.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance makes the process straightforward.
Who Should Use Lipocine Inc. (LPCN)?
- Healthcare Investors: Make informed investment choices with comprehensive analysis of Lipocine's pipeline and market potential.
- Pharmaceutical Analysts: Streamline your research with detailed reports on Lipocine's drug development progress and financial performance.
- Consultants: Easily modify presentations or reports to highlight Lipocine's strategic initiatives and market positioning.
- Biotech Enthusiasts: Enhance your knowledge of biopharmaceutical innovations and their impact on health outcomes through Lipocine's case studies.
- Educators and Students: Utilize Lipocine as a real-world example in pharmacology and business courses to illustrate industry concepts.
What the Template Contains
- Pre-Filled DCF Model: Lipocine Inc.'s (LPCN) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Lipocine Inc.'s (LPCN) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.